$MEND partners with an Oxford University Company Nurosene Health Inc. ( $MEND.C $MNNDF ) is a mental and physical health app and tech company that has a strong scientific and AI focus.
Today $MEND announced that it has partnered with Ni2o (an Oxford University company)
Ni2o will use Nurosene's NetraAI to support and accelerate research into neurodegenerative disease treatments by using NertaAI's patient maps and computational power in their brain implants.
Ni2o's implants are able to help damaged brain tissue using light and electrical impulses.
NetraAI can uncover precise insights about diseases like Alzheimer's, Parkinson's, and ALS through self-generating AI tech.
Full news here:
https://www.bloomberg.com/press-releases/2021-11-29/nurosene-partners-with-brain-computer-interface-technology-ni2o-to-pioneer-research-for-alzheimer-s-and-als